Mark A. Glickman, Chief Commercial Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 5,725 shares at $1.70 ($10K) on 2018-03-19, disclosed to the SEC on 2018-03-21.
Scheduled sale ($10k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AUXL | SELL | 2014-11-24 | $1.6M | — | Filing → |